查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
生物晶片市場 - 全球與區域分析 - 分析與預測（2024-2033）
市場調查報告書
商品編碼
1397891

生物晶片市場 - 全球與區域分析 - 分析與預測（2024-2033）

Biochips Market - A Global and Regional Analysis - Analysis and Forecast, 2024-2033
出版日期: 按訂單生產 | 出版商: BIS Research | 英文 | 商品交期: 7-10個工作天內

價格
簡介目錄

該報告考察了全球生物晶片市場，並提供了市場概況，包括按技術、最終用戶、類型、地區和參與市場的公司概況分類的趨勢。

目錄

執行摘要

範圍和定義

市場/產品定義

關鍵問題的答案

分析和預測注意事項

第1章市場：產業展望

  • 趨勢：當前和未來的影響評估
  • 供應鏈概覽
  • 研究發展回顧
  • 監管狀況
  • 市場動態概覽

第2章 生物晶片市場，依應用分類

  • 應用細分
  • 應用概述
  • 全球生物晶片市場
  • 依技術
  • 按最終用戶

第3章生物晶片市場，依類型

  • 產品細分
  • 產品概要
  • 全球生物晶片市場，按類型

第4章生物晶片市場，按地區

  • 區域概況
  • 促進因素和抑制因素
  • 北美洲
  • 歐洲
  • 亞太地區
  • 拉丁美洲
  • 中東/非洲

第5章市場-競爭形勢與公司概況

  • 競爭形勢
  • 公司簡介
    • Thermo Fisher Scientific, Inc.
    • Agilent Technologies, Inc.
    • PerkinElmer Inc.
    • Illumina Inc.
    • Bio-Rad Laboratories, Inc.
    • Standard Bio Tools
    • GE Healthcare
    • Li-COR Inc.
    • Qiagen
    • Randox Laboratories Ltd

第6章 成長機會與建議

第7章調查方法

簡介目錄
Product Code: BHP1695SA

The global biochip market report provides a comprehensive analysis of the industry, offering insights into key market trends, growth drivers, challenges, and opportunities, and forecast that a decision maker can take advantage of.

The market study encompasses a detailed examination of various applications including technological advancements, and market dynamics. It explores the market based on segmentations such as by application, by end user, and by product type and highlights the competitive landscape, profiling key players and their strategies for market expansion. The report delves into regional segmentation, evaluating market performance across different geographical areas. Additionally, it discusses the impact of macroeconomic factors on market growth and explores potential investment opportunities for stakeholders.

With a focus on fostering a deep understanding of market dynamics, the report serves as a valuable resource for businesses, investors, and industry participants seeking strategic insights into the evolving global biobanks market.

Market Segmentation:

Segmentation 1: by Technology

  • Microarrays
  • Microfluidics

Segmentation 2: by End User

  • Biotechnology and Pharmaceutical Companies
  • Hospitals and Diagnostic Centers
  • Academic & Research Institutes
  • Others

Segmentation 3: by Type

  • DNA Chips
  • Lab-on-Chip
  • Protein Chips
  • Other Arrays

Segmentation 4: by Region

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa

Key Questions Answered:

  • What are the major market drivers, challenges and opportunities in the global biochips market and their case studies?
  • How the biochips market evolves and what did is its scope in the future?
  • What is the market share of the leading segments and sub-segments of the global biochips market?
  • How will each segment of the global biochips market grow during the forecast period?
  • What are the influencing factors that may affect the market share of the key players?
  • How will the industry evolve during the forecast period?
  • What are the key developmental strategies implemented by the key players to stand out in this market?

Table of Contents

Executive Summary

Scope and Definition

Market/Product Definition

Key Questions Answered

Analysis and Forecast Note

1. Markets: Industry Outlook

  • 1.1. Trends: Current and Future Impact Assessment
  • 1.2. Supply Chain Overview
    • 1.2.1. Value chain Analysis
    • 1.2.2. Market Map
    • 1.2.3. Pricing Forecast
  • 1.3. R&D Review
    • 1.3.1. Patent Filing Trend by Country, by Company
  • 1.4. Regulatory Landscape
  • 1.5. Market Dynamics Overview
    • 1.5.1. Market Drivers
    • 1.5.2. Market Restraints
    • 1.5.3. Market Opportunities

2. Biochip Market by Application

  • 2.1. Application Segmentation
  • 2.2. Application Summary
  • 2.3. Global Biochip Market, by
    • 2.3.1. DNA Chips
      • 2.3.1.1. Gene Expression
      • 2.3.1.2. SNP Genotyping
      • 2.3.1.3. Cancer Diagnosis & Treatment
      • 2.3.1.4. Genomics
      • 2.3.1.5. Drug Discovery
      • 2.3.1.6. Agricultural Biotechnology
      • 2.3.1.7. Other DNA Chip Applications
    • 2.3.2. Lab-on-a-Chip Market
      • 2.3.2.1. Clinical Diagnostics
      • 2.3.2.2. Genomics
      • 2.3.2.3. IVD & POC
      • 2.3.2.4. Proteomics
      • 2.3.2.5. Drug Discovery
      • 2.3.2.6. Others
    • 2.3.3. Protein Chips Market
      • 2.3.3.1. Proteomics
      • 2.3.3.2. Expression Profiling
      • 2.3.3.3. Diagnostics
      • 2.3.3.4. High-Throughput Screening
      • 2.3.3.5. Drug Discovery
    • 2.3.4. Other Arrays
      • 2.3.4.1. Cell Arrays
      • 2.3.4.2. Tissue Arrays
  • 2.4. By Technology
    • 2.4.1. Microarrays
    • 2.4.2. Microfluidics
  • 2.5. By End User
    • 2.5.1. Biotechnology and Pharmaceutical Companies
    • 2.5.2. Hospitals and Diagnostic Centers
    • 2.5.3. Academic & Research Institutes
    • 2.5.4. Others

3. Biochip Market by Product

  • 3.1. Product Segmentation
  • 3.2. Product Summary
  • 3.3. Global Biochip Market, by Type
    • 3.3.1. DNA Chips
    • 3.3.2. Lab-on-Chip
    • 3.3.3. Protein Chips
    • 3.3.4. Other Arrays

4. Biochip Market by Region

  • 4.1. Regional Summary
  • 4.2. Drivers and Restraints
  • 4.3. North America
    • 4.3.1. Markets
      • 4.3.1.1. Key Market Participants in North America
      • 4.3.1.2. Business Drivers
      • 4.3.1.3. Business Challenges
    • 4.3.2. Application
    • 4.3.3. Product
    • 4.3.4. North America by Country
      • 4.3.4.1. U.S.
      • 4.3.4.2. Canada
  • 4.4. Europe
    • 4.4.1. Markets
      • 4.4.1.1. Key Market Participants in Europe
      • 4.4.1.2. Business Drivers
      • 4.4.1.3. Business Challenges
    • 4.4.2. Application
    • 4.4.3. Product
    • 4.4.4. Europe by Country
      • 4.4.4.1. U.K.
      • 4.4.4.2. Germany
      • 4.4.4.3. France
      • 4.4.4.4. Italy
      • 4.4.4.5. Spain
      • 4.4.4.6. Rest of Europe
  • 4.5. Asia-Pacific
    • 4.5.1. Markets
      • 4.5.1.1. Key Market Participants in Asia-Pacific
      • 4.5.1.2. Business Drivers
      • 4.5.1.3. Business Challenges
    • 4.5.2. Application
    • 4.5.3. Product
    • 4.5.4. Asia-Pacific by Country
      • 4.5.4.1. China
      • 4.5.4.2. Japan
      • 4.5.4.3. India
      • 4.5.4.4. South Korea
      • 4.5.4.5. Rest of Asia-Pacific
  • 4.6. Latin America
    • 4.6.1. Markets
      • 4.6.1.1. Key Market Participants in Latin America
      • 4.6.1.2. Business Drivers
      • 4.6.1.3. Business Challenges
    • 4.6.2. Application
    • 4.6.3. Product
    • 4.6.4. Latin America by Country
      • 4.6.4.1. Brazil
      • 4.6.4.2. Mexico
      • 4.6.4.3. Rest of Latin America
  • 4.7. Middle East and Africa
    • 4.7.1. Markets
      • 4.7.1.1. Key Market Participants in Middle East and Africa
      • 4.7.1.2. Business Drivers
      • 4.7.1.3. Business Challenges
    • 4.7.2. Application
    • 4.7.3. Product

5. Markets - Competitive Landscape & Company Profiles

  • 5.1. Competitive Landscape
  • 5.2. Company Profiles
    • 5.2.1. Thermo Fisher Scientific, Inc.
      • 5.2.1.1. Company Overview
      • 5.2.1.2. Top Products / Product Portfolio
      • 5.2.1.3. Top Competitors
      • 5.2.1.4. Target Customers /End-Users
      • 5.2.1.5. Key Personnel
      • 5.2.1.6. Market Share
      • 5.2.1.7. Analyst View
    • 5.2.2. Agilent Technologies, Inc.
      • 5.2.2.1. Company Overview
      • 5.2.2.2. Top Products / Product Portfolio
      • 5.2.2.3. Top Competitors
      • 5.2.2.4. Target Customers /End-Users
      • 5.2.2.5. Key Personnel
      • 5.2.2.6. Market Share
      • 5.2.2.7. Analyst View
    • 5.2.3. PerkinElmer Inc.
      • 5.2.3.1. Company Overview
      • 5.2.3.2. Top Products / Product Portfolio
      • 5.2.3.3. Top Competitors
      • 5.2.3.4. Target Customers /End-Users
      • 5.2.3.5. Key Personnel
      • 5.2.3.6. Market Share
      • 5.2.3.7. Analyst View
    • 5.2.4. Illumina Inc.
      • 5.2.4.1. Company Overview
      • 5.2.4.2. Top Products / Product Portfolio
      • 5.2.4.3. Top Competitors
      • 5.2.4.4. Target Customers /End-Users
      • 5.2.4.5. Key Personnel
      • 5.2.4.6. Market Share
      • 5.2.4.7. Analyst View
    • 5.2.5. Bio-Rad Laboratories, Inc.
      • 5.2.5.1. Company Overview
      • 5.2.5.2. Top Products / Product Portfolio
      • 5.2.5.3. Top Competitors
      • 5.2.5.4. Target Customers /End-Users
      • 5.2.5.5. Key Personnel
      • 5.2.5.6. Market Share
      • 5.2.5.7. Analyst View
    • 5.2.6. Standard Bio Tools
      • 5.2.6.1. Company Overview
      • 5.2.6.2. Top Products / Product Portfolio
      • 5.2.6.3. Top Competitors
      • 5.2.6.4. Target Customers /End-Users
      • 5.2.6.5. Key Personnel
      • 5.2.6.6. Market Share
      • 5.2.6.7. Analyst View
    • 5.2.7. GE Healthcare
      • 5.2.7.1. Company Overview
      • 5.2.7.2. Top Products / Product Portfolio
      • 5.2.7.3. Top Competitors
      • 5.2.7.4. Target Customers /End-Users
      • 5.2.7.5. Key Personnel
      • 5.2.7.6. Market Share
      • 5.2.7.7. Analyst View
    • 5.2.8. Li-COR Inc.
      • 5.2.8.1. Company Overview
      • 5.2.8.2. Top Products / Product Portfolio
      • 5.2.8.3. Top Competitors
      • 5.2.8.4. Target Customers /End-Users
      • 5.2.8.5. Key Personnel
      • 5.2.8.6. Market Share
      • 5.2.8.7. Analyst View
    • 5.2.9. Qiagen
      • 5.2.9.1. Company Overview
      • 5.2.9.2. Top Products / Product Portfolio
      • 5.2.9.3. Top Competitors
      • 5.2.9.4. Target Customers /End-Users
      • 5.2.9.5. Key Personnel
      • 5.2.9.6. Market Share
      • 5.2.9.7. Analyst View
    • 5.2.10. Randox Laboratories Ltd
      • 5.2.10.1. Company Overview
      • 5.2.10.2. Top Products / Product Portfolio
      • 5.2.10.3. Top Competitors
      • 5.2.10.4. Target Customers /End-Users
      • 5.2.10.5. Key Personnel
      • 5.2.10.6. Market Share
      • 5.2.10.7. Analyst View

6. Growth Opportunities & Recommendations

7. Research Methodology